Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

210.78
-21.2100-9.14%
Post-market: 212.771.99+0.94%19:59 EDT
Volume:426.63K
Turnover:92.65M
Market Cap:563.73M
PE:- -
High:229.00
Open:229.00
Low:210.16
Close:231.99
52wk High:341.93
52wk Low:102.35
Shares:2.67M
Float Shares:2.67M
Volume Ratio:0.68
T/O Rate:15.95%
Dividend:0.90
Dividend Rate:0.43%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Lancang Residents: 2027 Urban and Rural Resident Basic Medical Insurance Enrollment Opens Today

Deep News
·
Oct 10

FDA Warning Letter Could Be A Game Changer For Neogen Stock (NEOG)

Simply Wall St.
·
Oct 10

Health Care up as Humana Rallies

Dow Jones
·
Oct 10

Sector Update: Healthcare

MT Newswires Live
·
Oct 10

Sector Update: Healthcare

MT Newswires Live
·
Oct 10

Exchange-Traded Funds Rise as US Equities Advance After Midday

MT Newswires Live
·
Oct 10

Rubicon Research Reports Procedural Observation After Unannounced US FDA Inspection at Satara Plant

TIPRANKS
·
Oct 09

Looking for Dividend Aristocrats? These 3 Healthcare Stocks Deserve a Closer Look

TIPRANKS
·
Oct 09

Movement Alert|Direxion Daily S&P Biotech Bull 3x Shares Rises 8.25% in Regular Trading, Leveraged Biotech ETF Rebounds on Oversold Technical Repair

Market Focus
·
Oct 09

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), United Therapeutics (UTHR) and Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Oct 09

Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Veeva Systems (VEEV) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
Oct 09

Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Tilray (TLRY) and Viatris (VTRS)

TIPRANKS
·
Oct 09

Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial

GlobeNewswire
·
Oct 09

Teva Pharmaceutical Industries Says FDA Approved WELTRUZA for Schizophrenia in Adults

MT Newswires Live
·
Oct 09

Analysts’ Top Healthcare Picks: Biohaven Ltd. (BHVN), Clover Health Investments (CLOV)

TIPRANKS
·
Oct 09

Teva announces FDA approval for Weltruza

TIPRANKS
·
Oct 09

Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia

GlobeNewswire
·
Oct 09

National Healthcare Properties (NHP) Reaffirms Dividend, Is The Stock Still A Bargain?

Simply Wall St.
·
Oct 09

Health Care Roundup: Market Talk

Dow Jones
·
Oct 09

Humanwell Healthcare Unit Secures US FDA Nod for Angina Drug

MT Newswires Live
·
Oct 09